Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4846-4856
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4846
Table 4 Univariate and multivariate analyses of risk factors for eradication failure
VariableUnivariate analysis
Multivariate analysis
OR95%CIP valueOR95%CIP value
GenderMale1 (Reference)
Female1.2020.998-1.4470.052
Age1.0181.011-1.024< 0.0011.0141.008-1.021< 0.001
Eradication attemptsPrimary1 (Reference)1 (Reference)
Rescue1.8161.432-2.302< 0.0011.5381.179-2.0070.002
Antibiotic regimensAmoxicillin plus clarithromycin1 (Reference)1 (Reference)
Amoxicillin plus levofloxacin1.3470.761-2.3850.3061.1670.654-2.0840.601
Amoxicillin plus furazolidone1.3140.701-2.4610.3940.9820.505-1.9110.958
Clarithromycin plus metronidazole4.1792.928-5.966< 0.0013.1392.125-4.637< 0.001
Clarithromycin plus levofloxacin1.9581.599-2.397< 0.0011.8631.517-2.287< 0.001
Clarithromycin plus furazolidone6.43.200-12.797< 0.0015.7482.834-11.655< 0.001
Levofloxacin plus furazolidone2.9471.147-7.5740.0252.1150.798-5.6050.132
PPIsEsomeprazole1 (Reference)1 (Reference)
Rabeprazole1.1680.909-1.5020.2251.1380.879-1.4730.327
Lansoprazole1.1970.614-2.3320.5981.2620.638-2.4960.504
Pantoprazole1.5091.161-1.9610.0021.3981.067-1.8310.015
Omeprazole1.9631.482-2.600< 0.0011.5131.113-2.0560.008